Abiopharma

(99% Neutral) SURFACE ONCOLOGY, INC. (SURF) Files Form 8-K

(90% Positive) Global Blood Therapeutics, Inc. (GBT) Provides Update on study for order to help protect against end-organ damage

(10% Negative) IMAGO BIOSCIENCES, INC. (IMGO) Announces Delay in bomedemstat Trials for Total Symptom Score Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(90% Positive) Connect Biopharma Holdings Ltd (CNTB) Announces Clinical Development Update (Form 6-K)

(99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

(99% Neutral) EVELO BIOSCIENCES, INC. (EVLO) Files Form 8-K

(50% Neutral) Morphic Holding, Inc. (MORF) Announces Regulatory Update

(99% Neutral) RECURSION PHARMACEUTICALS, INC. (RXRX) Announces New Board Appointment

(99% Neutral) MeiraGTx Holdings plc (MGTX) Files Form 8-K

(99% Neutral) Solid Biosciences Inc. (SLDB) Announces Regulatory Update